Human parainfluenza viruses: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Shanshan Cen (talk | contribs) No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Parainfluenza virus TEM PHIL 271 lores.jpg|right|thumb|200px|right|Transmission electron micrograph of parainfluenza virus. Two intact particles and free filamentous nucleocapsid]] | [[Image:Parainfluenza virus TEM PHIL 271 lores.jpg|right|thumb|200px|right|Transmission electron micrograph of parainfluenza virus. Two intact particles and free filamentous nucleocapsid]] | ||
{{Human parainfluenza virus}} | {{Human parainfluenza virus}} | ||
'''For patient information click [[Human parainfluenza viruses (patient information)|here]].''' | |||
{{CMG}} | {{CMG}} | ||
Latest revision as of 18:57, 10 August 2015
Human parainfluenza viruses Microchapters |
Differentiating Human parainfluenza viruses from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Human parainfluenza viruses On the Web |
American Roentgen Ray Society Images of Human parainfluenza viruses |
Directions to Hospitals Treating Human parainfluenza viruses |
Risk calculators and risk factors for Human parainfluenza viruses |
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Human parainfluenza viruses from other Disorders
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies